These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 15037157)

  • 1. Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases.
    Montine KS; Quinn JF; Zhang J; Fessel JP; Roberts LJ; Morrow JD; Montine TJ
    Chem Phys Lipids; 2004 Mar; 128(1-2):117-24. PubMed ID: 15037157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. F2-isoprostanes in Alzheimer and other neurodegenerative diseases.
    Montine TJ; Montine KS; McMahan W; Markesbery WR; Quinn JF; Morrow JD
    Antioxid Redox Signal; 2005; 7(1-2):269-75. PubMed ID: 15650414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease.
    Montine TJ; Quinn JF; Milatovic D; Silbert LC; Dang T; Sanchez S; Terry E; Roberts LJ; Kaye JA; Morrow JD
    Ann Neurol; 2002 Aug; 52(2):175-9. PubMed ID: 12210787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of products of docosahexaenoic acid peroxidation, neuroprostanes, and neurofurans.
    Arneson KO; Roberts LJ
    Methods Enzymol; 2007; 433():127-43. PubMed ID: 17954232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid peroxidation in aging brain and Alzheimer's disease.
    Montine TJ; Neely MD; Quinn JF; Beal MF; Markesbery WR; Roberts LJ; Morrow JD
    Free Radic Biol Med; 2002 Sep; 33(5):620-6. PubMed ID: 12208348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of F4-neuroprostanes levels in cerebrospinal fluid with outcome of aneurysmal subarachnoid hemorrhage in humans.
    Hsieh YP; Lin CL; Shiue AL; Yin H; Morrow JD; Hsu JC; Hsieh TC; Wei HJ; Yen HC
    Free Radic Biol Med; 2009 Sep; 47(6):814-24. PubMed ID: 19555757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isofurans, but not F2-isoprostanes, are increased in the substantia nigra of patients with Parkinson's disease and with dementia with Lewy body disease.
    Fessel JP; Hulette C; Powell S; Roberts LJ; Zhang J
    J Neurochem; 2003 May; 85(3):645-50. PubMed ID: 12694390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased urinary F(2)-isoprostanes levels in the patients with Alzheimer's disease.
    Kim KM; Jung BH; Paeng KJ; Kim I; Chung BC
    Brain Res Bull; 2004 Jul; 64(1):47-51. PubMed ID: 15275956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease.
    Montine TJ; Markesbery WR; Morrow JD; Roberts LJ
    Ann Neurol; 1998 Sep; 44(3):410-3. PubMed ID: 9749613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of by-products of lipid oxidation in Alzheimer's disease brain: a focus on acrolein.
    Singh M; Dang TN; Arseneault M; Ramassamy C
    J Alzheimers Dis; 2010; 21(3):741-56. PubMed ID: 20634576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unresolved issues in the analysis of F2-isoprostanes, F4-neuroprostanes, isofurans, neurofurans, and F2-dihomo-isoprostanes in body fluids and tissue using gas chromatography/negative-ion chemical-ionization mass spectrometry.
    Yen HC; Wei HJ; Lin CL
    Free Radic Res; 2015; 49(7):861-80. PubMed ID: 25812589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation.
    Roberts LJ; Fessel JP
    Chem Phys Lipids; 2004 Mar; 128(1-2):173-86. PubMed ID: 15037162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E in neurodegenerative disorders: Alzheimer's disease.
    Kontush K; Schekatolina S
    Ann N Y Acad Sci; 2004 Dec; 1031():249-62. PubMed ID: 15753151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoprostanes and neuroprostanes: total synthesis, biological activity and biomarkers of oxidative stress in humans.
    Galano JM; Mas E; Barden A; Mori TA; Signorini C; De Felice C; Barrett A; Opere C; Pinot E; Schwedhelm E; Benndorf R; Roy J; Le Guennec JY; Oger C; Durand T
    Prostaglandins Other Lipid Mediat; 2013 Dec; 107():95-102. PubMed ID: 23644158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of F2-isoprostanes, F4-neuroprostanes, and total nitrate/nitrite in plasma and cerebrospinal fluid of patients with traumatic brain injury.
    Yen HC; Chen TW; Yang TC; Wei HJ; Hsu JC; Lin CL
    Free Radic Res; 2015; 49(12):1419-30. PubMed ID: 26271312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
    Ohrfelt A; Grognet P; Andreasen N; Wallin A; Vanmechelen E; Blennow K; Zetterberg H
    Neurosci Lett; 2009 Feb; 450(3):332-5. PubMed ID: 19022350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F(2)-isoprostanes as biomarkers of late-onset Alzheimer's disease.
    Montine TJ; Quinn J; Kaye J; Morrow JD
    J Mol Neurosci; 2007 Sep; 33(1):114-9. PubMed ID: 17901555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress.
    Milne GL; Yin H; Brooks JD; Sanchez S; Jackson Roberts L; Morrow JD
    Methods Enzymol; 2007; 433():113-26. PubMed ID: 17954231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity.
    Praticò D; Clark CM; Lee VM; Trojanowski JQ; Rokach J; FitzGerald GA
    Ann Neurol; 2000 Nov; 48(5):809-12. PubMed ID: 11079549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a role for isofurans and neuroprostanes in pre-eclampsia and normal pregnancy?
    Barden AE; Corcoran TB; Mas E; Durand T; Galano JM; Roberts LJ; Paech M; Muchatuta NA; Phillips M; Mori TA
    Antioxid Redox Signal; 2012 Jan; 16(2):165-9. PubMed ID: 21827297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.